Impact of Targeted Therapy on Cancer-Related Cognitive Impairment

Clinical trial NCT07638007 · RECRUITING

Trial details

NCT number: NCT07638007
Sponsor: University of Rochester NCORP Research Base
Status: RECRUITING
Study type: OBSERVATIONAL

Disease/Condition Name Cancer-related Cognitive Dysfunction Chronic Lymphocytic Leukemia (CLL)Chronic Myeloid Leukemia, BCR-ABL1 Positive

Start date: 2025-11-21
Primary completion: 2029-02-28
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.